Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level.

epidemiology hypertension stroke

Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
14 Dec 2020
Historique:
received: 11 05 2020
revised: 27 08 2020
accepted: 10 09 2020
entrez: 15 12 2020
pubmed: 16 12 2020
medline: 16 12 2020
Statut: aheadofprint

Résumé

Hypertension is the most important modifiable risk factor for stroke globally. We hypothesised that country-income level variations in knowledge, detection and treatment of hypertension may contribute to variations in the association of blood pressure with stroke. We undertook a standardised case-control study in 32 countries (INTERSTROKE). Cases were patients with acute first stroke (n=13 462) who were matched by age, sex and site to controls (n=13 483). We evaluated the associations of knowledge, awareness and treatment of hypertension with risk of stroke and its subtypes and whether this varied by gross national income (GNI) of country. We estimated OR and population attributable risk (PAR) associated with treated and untreated hypertension. Hypertension was associated with a graded increase in OR by reducing GNI, ranging from OR 1.92 (99% CI 1.48 to 2.49) to OR 3.27 (2.72 to 3.93) for highest to lowest country-level GNI (p-heterogeneity<0.0001). Untreated hypertension was associated with a higher OR for stroke (OR 5.25; 4.53 to 6.10) than treated hypertension (OR 2.60; 2.32 to 2.91) and younger age of first stroke (61.4 vs 65.4 years; p<0.01). Untreated hypertension was associated with a greater risk of intracerebral haemorrhage (OR 6.95; 5.61 to 8.60) than ischaemic stroke (OR 4.76; 3.99 to 5.68). The PAR associated with untreated hypertension was higher in lower-income regions, PAR 36.3%, 26.3%, 19.8% to 10.4% by increasing GNI of countries. Lifetime non-measurement of blood pressure was associated with stroke (OR 1.80; 1.32 to 2.46). Deficits in knowledge, detection and treatment of hypertension contribute to higher risk of stroke, younger age of onset and larger proportion of intracerebral haemorrhage in lower-income countries.

Identifiants

pubmed: 33318082
pii: heartjnl-2019-316515
doi: 10.1136/heartjnl-2019-316515
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Martin O' Donnell (M)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway, Ireland martin.odonnell@nuigalway.ie.

Graeme J Hankey (GJ)

Medical School, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.

Sumathy Rangarajan (S)

Dept of Medicine, Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.

Siu Lim Chin (SL)

Dept of Medicine, Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.

Purnima Rao-Melacini (P)

Dept of Medicine, Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.

John Ferguson (J)

National University of Ireland Galway, Galway, Ireland.

Denis Xavier (D)

St John's Research Insitiute, Bangalore, Karnataka, India.

Liu Lisheng (L)

National Center for Cardiovascular Diseases China, Xicheng District, Beijing, China.
Beijing Hypertension League Institute, Beijing, China.

Hongye Zhang (H)

Beijing Hypertension League Institute, Beijing, China.

Prem Pais (P)

St John's National Academy of Health Sciences, Bangalore, Karnataka, India.

Patricio Lopez-Jaramillo (P)

Instituto de Investigaciones MASIRA, Universidad de Santander, Bucaramanga, Colombia.

Albertino Damasceno (A)

Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.

Peter Langhorne (P)

Academic Section of Geriatric Medicine, Glasgow Royal Infirmary, University of Glasgow, Glasgow, UK.

Annika Rosengren (A)

Department of Molecular and Clinical Medicine, University of Gothenburg and Region Västra Götaland, Sahlgrenska University Hospital, Goteborg, Sweden.

Antonio L Dans (AL)

University of the Philippines Manila College of Medicine, Manila, Metro Manila, Philippines.

Ahmed Elsayed (A)

Alzaiem Alazhari University, Khartoum, Sudan.

Alvaro Avezum (A)

International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.

Charles Mondo (C)

Kiruddu National Referral Hospital, Kampala, Uganda.

Andrew Smyth (A)

National University of Ireland Galway, Galway, Ireland.

Conor Judge (C)

Medicine, National University of Ireland Galway, Galway, Galway, Ireland.

Hans-Christoph Diener (HC)

Department of Neurology, University Hospital Essen, Essen, Nordrhein-Westfalen, Germany.

Danuta Ryglewicz (D)

Military Institute of Aviation Medicine, Warsaw, Poland.

Anna Czlonkowska (A)

Military Institute of Aviation Medicine, Warsaw, Poland.

Nana Pogosova (N)

National Medical Research Center of Cardiology, Moscow, Russia, Moskva, Russian Federation.

Christian Weimar (C)

Neurology, Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany.
BDH-clinic Elzach, Elzach, Germany.

Romana Iqbal (R)

Department of Community Health Sciences and Medicine, Aga Khan University, Karachi, Pakistan.

Rafael Diaz (R)

Estudios Clínicos Latino America (ECLA), Instituto Cardiovascular de Rosario (ICR), Rosario, Argentina.

Khalid Yusoff (K)

Universiti Teknologi MARA, Selayang, Selangor and UCSI University, Kuala Lumpur, Malaysia.

Afzalhussein Yusufali (A)

Hatta Hospital, Dubai Health Authority/Dubai Medical College, Dubai, UAE.

Aytekin Oguz (A)

Department of Internal Medicine, Istanbul Medeniyet University, Istanbul, Istanbul, Turkey.

Xingyu Wang (X)

Laboratory of Human Genetics, Beijing Hypertension League Institute, Beijing, China.

Ernesto Penaherrera (E)

Department of Cardiology, Luis Vernaza General Hospital, Guayaquil, Guayas, Ecuador.

Fernando Lanas (F)

Internal Medicine, Universidad de La Frontera, Temuco, Chile.

Okechukwu Samuel Ogah (OS)

Division of Cardiology, University of Ibadan, Ibadan, Oyo, Nigeria.

Adensola Ogunniyi (A)

Neurology Unit, Department of Medicine, University College Hospital Ibadan, Ibadan, Oyo, Nigeria.

Helle K Iversen (HK)

Department of Neurology, University of Copenhagen, Rigshospitalet, Denmark.

German Malaga (G)

School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.

Zvonko Rumboldt (Z)

Department of Medicine, University of Split, Split, Splitsko-dalmatinska, Croatia.

Shahram Oveisgharan (S)

Rush University Medical Center, Chicago, Illinois, USA.

Fawaz AlHussain (F)

King Saud University, Riyadh, Riyadh Province, Saudi Arabia.

Magazi Daliwonga (M)

Department of Medicine, University of Limpopo, Sovenga, Limpopo, South Africa.

Yongchai Nilanont (Y)

Division of Neurology, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Salim Yusuf (S)

Dept of Medicine, Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.

Classifications MeSH